Vol. 20 No. 2 (2021)
Literature Review

Relationship between vitamin D and cancer: A narrative review

Published 2022-01-04

Keywords

  • Vitamin D,
  • Cancer,
  • Narrative review,
  • Cancer prevention,
  • Health problems

How to Cite

1.
L. Alves L, Torres-Nunes L, de Lucena-Machado M, A. de Azevedo YM, da C. de Sá-Caputo D, Bernardo-Filho M. Relationship between vitamin D and cancer: A narrative review. BJHBS [Internet]. 2022 Jan. 4 [cited 2024 Oct. 11];20(2):161-6. Available from: https://bjhbs.hupe.uerj.br/bjhbs/article/view/39

Abstract

Introduction: Vitamin D is involved in several human me-tabolism pathways, both in classic pathway, which involves the calcium and phosphorus metabolism, and in non-classic pathways, which are related to several types of diseases, includ-ing diseases related to muscles; kidneys; cardiovascular system; immune system; some types of cancer; diabetes; and pregnan-cy. Objectives: As cancer is one of the main health problems in the world and knowing that it is one of the non-classic effects related to vitamin D, the current narrative review aimed to verify the relevance of vitamin D has on the types of cancer. Methods: The bibliographic research was performed in data-bases Pubmed, Scopus and PEDro on June 16, 2020, using the keywords “vitamin D”, “cancer” and “non-classic”. Only articles since the year 2000 were included. Thirty-one articles were analyzed relating vitamin D to colon/rectum cancer, breast cancer, prostate cancer, lung cancer, ovarian cancer, melanoma and other types of skin cancer, and gastric cancer. Results: All studies have shown a relationship between vitamin D and the incidence of cancer in the human body, however, there are peculiarities regarding the concentration levels in each organ. Even with conflicting results, in general, vitamin D has shown to be promise in the prevention of several types of cancer.

Metrics

Metrics Loading ...

References

  1. Chang SW, Lee HC. Vitamin D and health - The missing vitamin in humans. Pediatr. Neonatol. 2019;60(3):237-244. doi:10/1016/j.pedneo.2019.04.007.
  2. Schalka S, Reis VMS. Sun protection factor: meaning and controversies. An Bras Dermatol. 2011;86(3):507-515. doi:10.1590/s036505962011000300013.
  3. Ureña-Torres P, Souberbielle JC. Pharmacologic role of vitamin D natural products. Curr Vasc Pharmacol. 2014;12(2):278-285.
  4. Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci. 2004;29(12):664-673. doi:10.1016/j.tibs.2004.10.005.
  5. Sliney DH. Radiometric quantities and units used in photobiology and photochemistry: recommendations of the commission internationale de l’Eclairage. Photochem Photobiol. 2007;83(2):425-432. doi:10.1562/2006-11-14-ra-1081.
  6. Castro LCG. The Vitamin D endocrine system. Arq Bras Endocrinol Metab. 2011;55(8):566-575. doi:10.1590/s0004-27302011000800010.
  7. Schlingmann KP, Kaufmann M, Weber S, et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med. 2011;365(5):410-421. doi:10.1056/nejmoa1103864.
  8. Dusso A, Lopez-Hilker S, Rapp N, et al. Extra-renal production of calcitriol in chronic renal failure. Kidney Int. 1988;34(3):368-375. doi:10.1038/ki.1988.190.
  9. World Health Organization. 2018. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. World Health Organization. https://apps.who.int/iris/handle/10665/279700. License: CC BY-NC-SA 3.0 IGO. Access in: 16/06/2020.
  10. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372(71). doi:10.1136/bmj.n71.
  11. Gandini S, Boniol M, Haukka J, et al. Meta-analysis of observational studies of sérum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer. 2011;128(6):1414-1424. doi:10.1002/ijc.25439.
  12. Lee JE, Li H, Chan AT, et al. Circulating levels of vitamin D and colon and rectal cancer: the Physicians’ Health Study and a meta-analysis of prospective studies. Cancer Prev Res. 2011;4(5):735-743. doi:10.1158/1940-6207.CAPR-10-0289.
  13. Touvier M, Chan DS, Lau R, et al. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidem Biomar Prev. 2011;20(5):1003-1016. doi:10.1158/1055-9965. EPI-10-1141.
  14. Uitterlinden AG, Fang Y, Van-Meurs JB, et al. Genetics and biology of vitaminD receptor polymorphisms. Gene. 2004;338(2):143-156. doi:10.1016/j.gene.2004.05.014.
  15. Boughanem H, Cabrera-Mulero A, Hernández-Alonso P, et al. Association between variation of circulating 25-OH vitamin D and methylation of secreted frizzled-related protein 2 in colorectal cancer. Clin Epigenetics. 2020;12(1):83-94. doi:10.1186/s13148-020-00875-9.
  16. Kimmie NG, Nimeiri HS, McCleary NJ, et al. Effect of high-dose vs standard-dose vitamin D3 supplementation on progression-free survival among patients with advanced or metastatic colorectal cancer: the sunshine randomized clinical trial. JAMA. 2019;321(14):1370-1379. doi:10.1001/jama.2019.2402.
  17. Messaritakis I, Koulouridi A, Sfakianaki M, et al. The Role of Vitamin D Receptor Gene Polymorphisms in Colorectal Cancer Risk. Cancers. 2020;12(6):1379-1395. doi:10.3390/cancers12061379.
  18. Shao T, Klein P, Grossbard ML. Vitamin D and breast câncer. Oncologist. 2012;17(1):36-45. doi:10.1634/theoncologist.2011-0278.
  19. Bauer SR, Hankinson SE, Bertone-Johnson ER, et al. Plasma vitamin D levels, menopause, and risk of breast câncer: dose-response meta-analysis of prospective studies. Medicine. 2013;92(3):123-131. doi:10.1097/MD.0b013e3182943bc2.
  20. Zhou L, Chen B, Sheng L, et al. The effect of vitamin D supplementation on the risk of breast cancer: a trial sequential meta-analysis. Breast Cancer Res Treat. 2020;182(1):1-8. doi:10.1007/s10549-020-05669-4.
  21. Xu Y, Shao X, Yao Y, et al. Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from and updated meta-analysis. J Cancer Res Clin Oncol. 2014;140(9):1465-1477. doi:10.1007/s00432-014-1706-3.
  22. Nair-Shalliker V, Bang A, Egger S, et al. Post-treatment levels of plasma 25- and 1,25-dihydroxy vitamin D and mortality in men with aggressive prostate cancer. Sci Rep. 2020;10(1):7736-7747. doi:10.1038/s41598-020-62182-w.
  23. Torkko K, Till C, Tangen CM, et al. Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial. Cancer Prev Res. 2020;13(6):521-530. doi:10.1158/1940-6207.capr-19-0413.
  24. Zhang L, Wang S, Che X, et al. Vitamin D and lung cancer risk: a comprehensive review and meta-analysis. Cell Physiol Biochem. 2015;36(1):299-305. doi:10.1159/000374072.
  25. Chen GC, Zhang ZL, Wan Z, et al. Circulating 25- hydroxyvitamin D and risk of lung cancer: a dose-response meta-analysis. Cancer Causes Control. 2015;26(12):1719-1728. doi:10.1007/s10552-015-0665-6.
  26. Kong J, Chen X, Wang J, et al. Genetic Polymorphisms in the Vitamin D Pathway and Non-small Cell Lung Cancer Survival. Path Oncol Res. 2020;26(3):1709-1715. doi:10.1007/s12253- 019- 00702-4.
  27. Yin L, Grandi N, Raum E, et al. Meta-analysis: circulating vitamin D and ovarian cancer risk. Gynecol Oncol. 2011;121(2):369-375. doi:10.1016/j.ygyno.2011.01.023.
  28. Ji J, Cheng X, Wang W, et al. Vitamin D regulates cell viability, migration and proliferation by suppressing galectin-3 (Gal-3) gene in ovarian cancer cells. J Biosci. 2020;45(1):69-79. doi:10.1007/s12038-020-00038-1.
  29. Caini S, Boniol M, Tosti G, et al. Vitamin D and melanoma and non-melanoma skin cancer and prognosis: A comprehensive review and meta-analysis. Eur J Cancer. 2014;50(15):2649-2658. doi:10.1016/j.ejca.2014.06.024.
  30. Du C, Yang S, Zhao X, et al. Pathogenic roles of alterations in vitamin D and vitamin D receptor in gastric tumorigenesis. Oncotarget. 2017;8(17),29474-29486. doi:10.18632/oncotarget.15298.
  31. Nasri H, Baradaran A. The influence of serum 25-hydroxy vitamin D levels on Helicobacter Pylori infections in patients with end-stage renal failure on regular hemodialysis. Saudi J of Kidney Dis and Transpl. 2007;18(2):215-219.
  32. Li M, Li I, Zhang L, et al. 1,25-Dihydroxyvitamin D3 suppresses gastric cancer cell growth through VDR and mutant p53-mediated induction of p21. Life Sci. 2017;179:88-97. doi:10.1016/j.lfs.2017.04.021.
  33. Jeon S, Shin E. Exploring vitamin D metabolism and function in cancer. Exp Mol Med. 2018;50(4):20-34. doi:10.1038/s12276-018- 0038-9.
  34. Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature. 2008;454(7203):436-444. doi:10.1038/nature07205.
  35. Krishnan AV, Feldman D. Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemo-prevention and treatment. Endocr Relat Cancer. 2010;17(1):R19-R38. doi:10.1677/ERC-09-0139.
  36. Nonn L, Peng L, Feldman D, et al. Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D. Cancer Res. 2006;66(8):4516-4524. doi:10.1158/0008-5472.CAN-05-3796.
  37. Wang Q, He Y, Shen Y et al. Vitamin D inhibits COX- 2 expression and inflammatory response by targeting thioesterase superfamily member 4. The J Biol Chem. 2014;289(17):11681-11694. doi:10.1074/jbc.M113.517581.
  38. Bessler H, Djaldetti M. 1alpha,25-Dihydroxyvitamin D3 modulates the interaction between immune and colon cancer cells. Biomed Pharmacother. 2012;66(6):428-432. doi:10.1016/j.biopha.2012.06.005.
  39. Uberti F, Morsanuto V, Molinari C. Vitamin D in oxidative stress and diseases. A critical evaluation of vitamin D - basic overview. InTech Rijeka. 2017;2:47-73. doi:10.5772/64506.
  40. Nair-Shalliker V, Armstrong BK, Fenech M. Does vitamin D protect against DNA damage? Mutat Res. 2012;733(1-2):50-57. doi:10.1016/j.mrfmmm.2012.02.005.